Home -> Proteomics -> Red Fluorescent Protein: Supermonomeric FusionRed

Red Fluorescent Protein: Supermonomeric FusionRed

Red Fluorescent Protein FusionRed
• Superior performance in fusions
• Low cytotoxicity
• Fast maturation, high pH-stability and photostability
• Proven suitability to generate stably transfected cell lines
• Recommended for protein labeling and long-term experiments incl. transgenic animal generation


FusionRed is a red fluorescent protein characterized by improved performance in fusions and low toxicity [Shemiakina et al., 2012, Nat Commun. 2012; 3 :1204. / pmid: 23149748].
FusionRed lacks the residual tendency of other monomeric RFPs to dimerize at high concentration and behaves as a pure monomer at concentrations up to 10 mg/ml in HPLC analysis. Such "supermonomeric" properties ensure superior efficiency of FusionRed in protein labeling applications, especially in cells with high expression level.

Similarly to parental mKate2, FusionRed demonstrates fast maturation rate, high pH-stability and photostability, and significantly lower cytotoxicity than widely used mCherry [Shaner et al., 2004, Nat Biotechnol. 2004; 22 (12):1567-72. / pmid: 15558047] and mRuby [Kredel et al., 2009, PLoS One. 2009; 4 (2):e4391. / pmid: 19194514].

FusionRed is mainly intended for protein labeling and long-term experiments including generation of transgenic animals.

FusionRed normalized excitation (thin line) and emission (thick line) spectra.

HPLC analysis of FusionRed in comparison with selected fluorescent proteins loaded in a high concentration.
FusionRed – orange line, mKate2 – black line, mNeptune – gray line. Proteins were loaded at a concentration of 10 mg/ml. While HPLC demonstrates reversible dimerization of mKate2 and reveals a dimeric character for the mKate derivative, far-red fluorescent protein mNeptune [Lin et al., 2009], FusionRed behaves as a pure monomer. Data from Shemiakina et al., 2012

FusionRed Characteristics

Molecular weight: kDa 26
Polypeptide length: aa 232
Fluorescence color: red
Excitation maximum: nm 580
Emission maximum: nm 608
Quantum yield: 0.19
Extinction coefficient: M-1cm-1 94 500
Brightness*: 18.0
Brightness, % of EGFP: 53
pKa: 4.6
Structure: supermonomer**
Aggregation: no
Maturation: half-time, min 130
Photostability, widefield***: 150
Photostability, confocal***: 176
Cell toxicity: not observed
Possible limitations: superior performance in fusions, low cytotoxicity

* Brightness is a product of extinction coefficient and quantum yield, divided by 1000.
** Purified recombinant protein behaves as a pure monomer at concentrations of 10 mg/ml as verified by high-performance liquid chromatography (HPLC)
*** Time to bleach 50% of fluorescent signal brightness.

Recommended filter sets and antibodies

FusionRed can be detected using TRITC filter set or similar. Recommended Omega Optical filter sets are QMAX-Red and XF102-2.

FusionRed can be recognized using Anti-tRFP antibody (Cat.# AB233-EV and AB234-EV, see links below)

Performance and use

FusionRed can be easily expressed and detected in a wide range of organisms. Mammalian cells transiently transfected with FusionRed expression vectors produce bright fluorescence in 10-12 hours after transfection. FusionRed performance in fusions has been demonstrated in a number of models.

FusionRed use for protein labeling in mammalian cells:
Scale bars represent 10 um. Data from Shemiakina et al., 2012

Labeling efficiency testing:
The performance of FusionRed and mCherry was directly compared in HeLa CCL2 cells for the following targets: connexin-43, endosomes, vinculin, and the Golgi complex. In this experiment, the cells were transfected with each of the four target fusions, fixed, and then compared for localization efficiency, which was determined by calculating the percentage of properly expressing cells versus the total number of transfected cells. FusionRed demonstrated clear advantage in all four fusions. Data from Shemiakina et al., 2012

Cytotoxicity testing in HeLa cells:
The cytotoxicity of FusionRed relative to selected red fluorescent proteins and EGFP was evaluated in the following experiment: HeLa cells were transfected with appropriate vectors encoding EGFP or one of the following red fluorescent proteins: mRuby, FusionRed, mKate2 or mCherry. Next, the EGFP-expressing cells were mixed with those expressing one of the RFPs, resulting in 4 separate cell mixtures: EGFP and mRuby, EGFP and FusionRed, EGFP and mKate2, and EGFP and mCherry. 48 hours after transfection, the green-to-red cell ratios were calculated utilizing flow cytometry and each of the cell mixtures were then plated into 3 plates. After additional 92 hour incubation, the green-to-red cell ratios were recalculated. Because only living cells were counted for this experiment, the difference between the ratios before and after the incubation can be assumed to accurately reflect RFP toxicity versus EGFP. mRuby exhibited a more than 10-fold higher cytotoxicity level compared to EGFP, while the remaining RFPs were almost as cytotoxic as EGFP in this experiment. Data from Shemiakina et al., 2012

Cytotoxicity testing in Xenopus laevis tadpoles:
Stage 41 Xenopus laevis tadpoles expressing fluorescent protein fusions. Top panels: white light; bottom panels: fluorescence. Data from Shemiakina et al., 2012

The eye formation is a complex multistage process that depends on many mechanisms, any disturbance of which may result in an abnormal phenotype. Here eye development was used as a sensitive readout of possible abnormal course of embryogenesis caused by expression of EGFP, FusionRed, and mCherry fusions. In these experiments, actin and vimentin fusions of EGFP and FusionRed were only slightly more toxic than the uninjected controls, while expression of mCherry fusions led to notable decrease of the average eye size. Moreover, in many cases (80% of tadpoles with the reduced eye size), the reduced eye phenotype was accompanied by varying degree of an unclosed optic fissure, indicating an abnormal eye development.

Upper graph: Mean values of eye size of Xenopus laevis embryos injected with plasmids expressing different fluorescent protein fusions.
Lower graph: Percentage of reduced eyes with unclosed optic fissure.

Data from Shemiakina et al., 2012

Long-term expression:
The excellent suitability of FusionRed for long-term experiments was proven both in experiments with stably transfected cell lines and in transgenic animals. In addition to its low cytotoxicity, FusionRed does not show abnormal lysosomal localization typical for many fluorescent proteins in long-term expression.
Being expressed in HeLa cells, both mKate2 and FusionRed remain evenly localized in cytoplasm after 96 hours of cultivation, while mCherry and mRuby show abnormal lysosomal localization.

Data from Shemiakina et al., 2012

Related Links

Anti-tRFP antibody detecting FusionRed Protein (100 ug)

BioCat Summer Special

% Special Offers

Benefit from our current promotions


NEW! Tools for


30% OFF BioCat Universal Agarose

Quantibody Arrays

Simultaneously quantify up to 1,000 cytokines using glass-based antibody arrays

Email Newsletter

Subscribe to the BioCat Email Newsletter.


Bioline Products at BioCat

Peptide Microarrays

Peptide Microarray

Benefit from PEPperCHIP Custom Peptide Microarrays fully tailored to your scientific needs.

TrueMAB Antibodies

TrueMab Antibodies

Use TrueMAB Monoclonal Antibodies raised against authentic protein antigens for immunoassays where a protein's native conformation is a critical parameter.

Protein Extraction

Protein Extraction

Apply spin column-based Minute Protein Extraction Kits for rapid and easy protein extraction and fractionation.

Imprint / Impressum | Privacy Policy / Datenschutzerklärung
Top of Page Up!